Vertex Pharma (VRTX) June volatility elevated into data

Vertex Pharma (Nasdaq: VRTX) PDUFA date for Incivek, (hepatitis C virus treatment) is expected on May 23. May put option implied volatility is at 62, June is at 56, July at 49; compared to its six-month average of 42 according to Track Data.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• RH (RH) call put ratio 2.1 calls to 1 put with a focus on June 12 weekly 165 calls into quarter results
• Grupo Financiero Galicia Sa (GGAL) spreader of July 40 and October 39 puts
• West Pharma (WST) June calls active